256 related articles for article (PubMed ID: 33259671)
1. Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study.
Casula M; Gazzotti M; Bonaiti F; OImastroni E; Arca M; Averna M; Zambon A; Catapano AL;
J Intern Med; 2021 Jul; 290(1):116-128. PubMed ID: 33259671
[TBL] [Abstract][Full Text] [Related]
2. Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy.
Vinci P; Panizon E; Tosoni LM; Cerrato C; Pellicori F; Mearelli F; Biasinutto C; Fiotti N; Di Girolamo FG; Biolo G
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769118
[TBL] [Abstract][Full Text] [Related]
3. Update on SAMS: Statin-associated muscle symptoms.
Stock JK
Atherosclerosis; 2018 Feb; 269():260-261. PubMed ID: 29361270
[No Abstract] [Full Text] [Related]
4. Management Strategies for Statin-Associated Muscle Symptoms: How Useful Is Same-Statin Rechallenge?
Brennan ET; Joy TR
Can J Cardiol; 2017 May; 33(5):666-673. PubMed ID: 28449837
[TBL] [Abstract][Full Text] [Related]
5. Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects.
Peersen K; Munkhaugen J; Sverre E; Kristiansen O; Fagerland M; Vethe NT; Perk J; Husebye E; Dammen T
BMC Cardiovasc Disord; 2021 Dec; 21(1):596. PubMed ID: 34915854
[TBL] [Abstract][Full Text] [Related]
6. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
Stroes ES; Thompson PD; Corsini A; Vladutiu GD; Raal FJ; Ray KK; Roden M; Stein E; Tokgözoğlu L; Nordestgaard BG; Bruckert E; De Backer G; Krauss RM; Laufs U; Santos RD; Hegele RA; Hovingh GK; Leiter LA; Mach F; März W; Newman CB; Wiklund O; Jacobson TA; Catapano AL; Chapman MJ; Ginsberg HN;
Eur Heart J; 2015 May; 36(17):1012-22. PubMed ID: 25694464
[TBL] [Abstract][Full Text] [Related]
7. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
Nichols GA; Koro CE
Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
[TBL] [Abstract][Full Text] [Related]
8. Statin-associated muscle symptoms in coronary patients: design of a randomized study.
Munkhaugen J; Vethe NT; Fagerland MW; Dammen T; Perk J; Gjertsen E; Otterstad JE; Gullestad L; Bergan S; Husebye E
Scand Cardiovasc J; 2019 Jun; 53(3):162-168. PubMed ID: 31030568
[No Abstract] [Full Text] [Related]
9. Statin-Associated Muscle Disease: Advances in Diagnosis and Management.
Taylor BA; Thompson PD
Neurotherapeutics; 2018 Oct; 15(4):1006-1017. PubMed ID: 30251222
[TBL] [Abstract][Full Text] [Related]
10. Muscle and statins: from toxicity to the nocebo effect.
Pedro-Botet J; Climent E; Benaiges D
Expert Opin Drug Saf; 2019 Jul; 18(7):573-579. PubMed ID: 31070941
[TBL] [Abstract][Full Text] [Related]
11. Biochemical markers of muscle damage and high serum concentration of creatine kinase in patients on statin therapy.
Nogueira AA; Strunz CM; Takada JY; Mansur AP
Biomark Med; 2019 Jun; 13(8):619-626. PubMed ID: 31157560
[No Abstract] [Full Text] [Related]
12. No benefit of vitamin D supplementation on muscle function and health-related quality of life in primary cardiovascular prevention patients with statin-associated muscle symptoms: A randomized controlled trial.
Peyrel P; Mauriège P; Frenette J; Laflamme N; Greffard K; Dufresne SS; Huth C; Bergeron J; Joanisse DR
J Clin Lipidol; 2024; 18(2):e269-e284. PubMed ID: 38177036
[TBL] [Abstract][Full Text] [Related]
13. Statin intolerance.
Ahmad Z
Am J Cardiol; 2014 May; 113(10):1765-71. PubMed ID: 24792743
[TBL] [Abstract][Full Text] [Related]
14. Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association.
Warden BA; Guyton JR; Kovacs AC; Durham JA; Jones LK; Dixon DL; Jacobson TA; Duell PB
J Clin Lipidol; 2023; 17(1):19-39. PubMed ID: 36115813
[TBL] [Abstract][Full Text] [Related]
15. Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.
Banach M; Rizzo M; Toth PP; Farnier M; Davidson MH; Al-Rasadi K; Aronow WS; Athyros V; Djuric DM; Ezhov MV; Greenfield RS; Hovingh GK; Kostner K; Serban C; Lighezan D; Fras Z; Moriarty PM; Muntner P; Goudev A; Ceska R; Nicholls SJ; Broncel M; Nikolic D; Pella D; Puri R; Rysz J; Wong ND; Bajnok L; Jones SR; Ray KK; Mikhailidis DP
Expert Opin Drug Saf; 2015 Jun; 14(6):935-55. PubMed ID: 25907232
[TBL] [Abstract][Full Text] [Related]
16. Treatment Options for Statin-Associated Muscle Symptoms.
Laufs U; Scharnagl H; Halle M; Windler E; Endres M; März W
Dtsch Arztebl Int; 2015 Oct; 112(44):748-55. PubMed ID: 26575138
[TBL] [Abstract][Full Text] [Related]
17. Statin myopathy: a lipid clinic experience on the tolerability of statin rechallenge.
Fung EC; Crook MA
Cardiovasc Ther; 2012 Oct; 30(5):e212-8. PubMed ID: 21884002
[TBL] [Abstract][Full Text] [Related]
18. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
[TBL] [Abstract][Full Text] [Related]
19. Coenzyme Q10 supplementation for the treatment of statin-associated muscle symptoms.
Chen W; Ochs-Balcom HM; Ma C; Isackson PJ; Vladutiu GD; Luzum JA
Future Cardiol; 2022 Jun; 18(6):461-470. PubMed ID: 35297269
[TBL] [Abstract][Full Text] [Related]
20. [Muscle problems due to statins: underestimated].
Janssen SP; Smulders YM; Gerdes VE; Visseren FL
Ned Tijdschr Geneeskd; 2010; 154():A1684. PubMed ID: 21435278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]